We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
-0.89%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$849M
AUM Growth
+$64.3M
Cap. Flow
-$13.5M
Cap. Flow %
-1.59%
Top 10 Hldgs %
45.35%
Holding
87
New
28
Increased
23
Reduced
11
Closed
22

Top Buys

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$19.2M
2
INCY icon
Incyte
INCY
+$18.5M
3
ASRT
Assertio
ASRT
+$17.4M
4
DKS icon
Dick's Sporting Goods
DKS
+$15.9M
5
CPB icon
Campbell Soup
CPB
+$15M

Top Sells

Rank Stock Value
1
HAIN icon
Hain Celestial
HAIN
+$27.8M
2
SGI
Somnigroup International
SGI
+$20.7M
3
PRKS icon
United Parks & Resorts
PRKS
+$13.7M
4
GCI
Gannett Co., Inc
GCI
+$13.4M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$12.2M

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.37%
2 Healthcare 32.65%
3 Consumer Discretionary 19.4%
4 Consumer Staples 9.7%
5 Industrials 3.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
$146M 17.16%
580,000
+20,000
+4% +$4.93M
HAIN icon
2
CALL
Hain Celestial
HAIN
$67.5M
$37M 4.36%
+900,000
New +$37.2M
DECK icon
3
CALL
Deckers Outdoor
DECK
$11.7B
$34.2M 4.03%
3,000,000
+600,000
+25% +$6.47M
VNDA icon
4
Vanda Pharmaceuticals
VNDA
$328M
$27.4M 3.23%
1,532,000
-532,000
-26% -$8.9M
ASRT
5
DELISTED
Assertio
ASRT
$26.9M 3.17%
77,533
+37,000
+91% +$17.4M
ENR icon
6
Energizer
ENR
$1.45B
$24.1M 2.84%
524,000
+174,000
+50% +$7.84M
CPB icon
7
CALL
Campbell Soup
CPB
$6.38B
$23.4M 2.76%
500,000
+20,000
+4% +$1.01M
REGN icon
8
Regeneron Pharmaceuticals
REGN
$85.2B
$22.4M 2.63%
50,000
+6,000
+14% +$2.86M
FRPT icon
9
Freshpet
FRPT
$3.38B
$22.1M 2.6%
1,412,000
+80,000
+6% +$1.29M
NOMD icon
10
Nomad Foods
NOMD
$1.63B
$21.7M 2.55%
1,488,000
+32,000
+2% +$467K
AVDL
11
DELISTED
Avadel Pharmaceuticals
AVDL
$17.7M 2.09%
1,688,000
+538,000
+47% +$5.14M
UTHR icon
12
United Therapeutics
UTHR
$20.9B
$17.6M 2.07%
+150,000
New +$19.2M
INCY icon
13
Incyte
INCY
$25.7B
$17M 2.01%
+146,000
New +$18.5M
PLYA
14
DELISTED
Playa Hotels & Resorts
PLYA
$17M 2%
1,628,000
+378,000
+30% +$4.27M
QVCGA
15
DELISTED
QVC Group Inc Series A
QVCGA
$16.5M 1.94%
14,420
+4,779
+50% +$5.36M
ADMS
16
DELISTED
Adamas Pharmaceuticals
ADMS
$15.9M 1.87%
750,000
-408,000
-35% -$7.48M
SHPG
17
CALL
DELISTED
Shire pic
SHPG
$15.3M 1.8%
+100,000
New +$15.7M
CPB icon
18
Campbell Soup
CPB
$6.38B
$13.9M 1.63%
+296,000
New +$15M
CAKE icon
19
Cheesecake Factory
CAKE
$5.35B
$13.6M 1.61%
+324,000
New +$14.4M
ATRS
20
DELISTED
Antares Pharma, Inc.
ATRS
$13.6M 1.6%
4,200,000
-1,500,000
-26% -$4.63M
AVTX icon
21
Avalo Therapeutics
AVTX
$1.03B
$13.6M 1.6%
5,556
+4,381
+373% +$9.38M
DKS icon
22
Dick's Sporting Goods
DKS
$12.4B
$13.5M 1.59%
+500,000
New +$15.9M
TLRD
23
DELISTED
Tailored Brands, Inc.
TLRD
$13.5M 1.59%
932,000
+782,000
+521% +$9.52M
NVLN
24
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$13M 1.54%
1,856,000
+4,000
+0.2% +$32.1K
SGI
25
CALL
Somnigroup International
SGI
$14.7B
$12.9M 1.52%
+800,000
New +$11.8M
1
2 3 4

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Armistice Capital held 87 positions worth $849M, up 8.2% from $785M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Armistice Capital's Q3 2017 filing shows 28 new, 23 increased, 11 reduced and 22 closed positions. Its largest new stake was United Therapeutics: 150,000 shares worth $17.6M. The largest sale was Hain Celestial, an estimated $27.8M.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Armistice Capital's largest Q3 2017 buy was United Therapeutics: 150,000 shares worth $17.6M.
  • Armistice Capital added most to Assertio in Q3 2017, an estimated $17.4M increase.
  • Armistice Capital's biggest Q3 2017 reduction was Momenta Pharmaceuticals, Inc., cutting an estimated $11.5M.
  • Armistice Capital fully exited Hain Celestial in Q3 2017, selling an estimated $27.8M.
  • Armistice Capital's ten largest holdings make up 45% of its $849M portfolio in Q3 2017.
  • Armistice Capital opened 28 new positions and closed 22 in Q3 2017.
  • Armistice Capital's portfolio value rose 8.2% quarter-over-quarter to $849M.

Based on Armistice Capital's 13F filing for Q3 2017, filed 14 Nov 2017.